1634 related articles for article (PubMed ID: 29879316)
1. GLUT9 influences uric acid concentration in patients with Lesch-Nyhan disease.
Torres RJ; Puig JG
Int J Rheum Dis; 2018 Jun; 21(6):1270-1276. PubMed ID: 29879316
[TBL] [Abstract][Full Text] [Related]
2. Tubular urate transporter gene polymorphisms differentiate patients with gout who have normal and decreased urinary uric acid excretion.
Torres RJ; de Miguel E; Bailén R; Banegas JR; Puig JG
J Rheumatol; 2014 Sep; 41(9):1863-70. PubMed ID: 25128519
[TBL] [Abstract][Full Text] [Related]
3. Complex analysis of urate transporters SLC2A9, SLC22A12 and functional characterization of non-synonymous allelic variants of GLUT9 in the Czech population: no evidence of effect on hyperuricemia and gout.
Hurba O; Mancikova A; Krylov V; Pavlikova M; Pavelka K; Stibůrková B
PLoS One; 2014; 9(9):e107902. PubMed ID: 25268603
[TBL] [Abstract][Full Text] [Related]
4. The genetics of hyperuricaemia and gout.
Reginato AM; Mount DB; Yang I; Choi HK
Nat Rev Rheumatol; 2012 Oct; 8(10):610-21. PubMed ID: 22945592
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of allopurinol in patients with hypoxanthine-guanine phosphoribosyltransferase deficiency.
Torres RJ; Prior C; Puig JG
Metabolism; 2007 Sep; 56(9):1179-86. PubMed ID: 17697859
[TBL] [Abstract][Full Text] [Related]
6. ABCG2 rs2231142 variant in hyperuricemia is modified by SLC2A9 and SLC22A12 polymorphisms and cardiovascular risk factors in an elderly community-dwelling population.
Liu J; Yang W; Li Y; Wei Z; Dan X
BMC Med Genet; 2020 Mar; 21(1):54. PubMed ID: 32183743
[TBL] [Abstract][Full Text] [Related]
7. The association between genetic polymorphisms in ABCG2 and SLC2A9 and urate: an updated systematic review and meta-analysis.
Lukkunaprasit T; Rattanasiri S; Turongkaravee S; Suvannang N; Ingsathit A; Attia J; Thakkinstian A
BMC Med Genet; 2020 Oct; 21(1):210. PubMed ID: 33087043
[TBL] [Abstract][Full Text] [Related]
8. Polymorphisms of
Duong NT; Ngoc NT; Thang NTM; Phuong BTH; Nga NT; Tinh ND; Quynh DH; Ton ND; Hai NV
Medicina (Kaunas); 2019 Jan; 55(1):. PubMed ID: 30621105
[No Abstract] [Full Text] [Related]
9. Plasma urate level is directly regulated by a voltage-driven urate efflux transporter URATv1 (SLC2A9) in humans.
Anzai N; Ichida K; Jutabha P; Kimura T; Babu E; Jin CJ; Srivastava S; Kitamura K; Hisatome I; Endou H; Sakurai H
J Biol Chem; 2008 Oct; 283(40):26834-8. PubMed ID: 18701466
[TBL] [Abstract][Full Text] [Related]
10. Genome-wide association study identifies ABCG2 (BCRP) as an allopurinol transporter and a determinant of drug response.
Wen CC; Yee SW; Liang X; Hoffmann TJ; Kvale MN; Banda Y; Jorgenson E; Schaefer C; Risch N; Giacomini KM
Clin Pharmacol Ther; 2015 May; 97(5):518-25. PubMed ID: 25676789
[TBL] [Abstract][Full Text] [Related]
11. Recent advances in renal urate transport: characterization of candidate transporters indicated by genome-wide association studies.
Anzai N; Jutabha P; Amonpatumrat-Takahashi S; Sakurai H
Clin Exp Nephrol; 2012 Feb; 16(1):89-95. PubMed ID: 22038265
[TBL] [Abstract][Full Text] [Related]
12. ABCG2 loss-of-function polymorphism predicts poor response to allopurinol in patients with gout.
Roberts RL; Wallace MC; Phipps-Green AJ; Topless R; Drake JM; Tan P; Dalbeth N; Merriman TR; Stamp LK
Pharmacogenomics J; 2017 Mar; 17(2):201-203. PubMed ID: 26810134
[TBL] [Abstract][Full Text] [Related]
13. Genetic background of uric acid metabolism in a patient with severe chronic tophaceous gout.
Petru L; Pavelcova K; Sebesta I; Stiburkova B
Clin Chim Acta; 2016 Sep; 460():46-9. PubMed ID: 27288985
[TBL] [Abstract][Full Text] [Related]
14. Genetics of hyperuricemia and gout: implications for the present and future.
George RL; Keenan RT
Curr Rheumatol Rep; 2013 Feb; 15(2):309. PubMed ID: 23307580
[TBL] [Abstract][Full Text] [Related]
15. ABCG2 as a therapeutic target candidate for gout.
Fujita K; Ichida K
Expert Opin Ther Targets; 2018 Feb; 22(2):123-129. PubMed ID: 29264928
[TBL] [Abstract][Full Text] [Related]
16. The impact of dysfunctional variants of ABCG2 on hyperuricemia and gout in pediatric-onset patients.
Stiburkova B; Pavelcova K; Pavlikova M; Ješina P; Pavelka K
Arthritis Res Ther; 2019 Mar; 21(1):77. PubMed ID: 30894219
[TBL] [Abstract][Full Text] [Related]
17. Genetics of gout.
Choi HK; Zhu Y; Mount DB
Curr Opin Rheumatol; 2010 Mar; 22(2):144-51. PubMed ID: 20110790
[TBL] [Abstract][Full Text] [Related]
18. Identification of Two Dysfunctional Variants in the ABCG2 Urate Transporter Associated with Pediatric-Onset of Familial Hyperuricemia and Early-Onset Gout.
Toyoda Y; Pavelcová K; Bohatá J; Ješina P; Kubota Y; Suzuki H; Takada T; Stiburkova B
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33669292
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of allopurinol in patients with the Lesch-Nyhan syndrome and partial hypoxanthine- phosphoribosyltransferase deficiency: a follow-up study of 18 Spanish patients.
Torres RJ; Prior C; Puig JG
Nucleosides Nucleotides Nucleic Acids; 2006; 25(9-11):1077-82. PubMed ID: 17065067
[TBL] [Abstract][Full Text] [Related]
20. Baicalein alleviates hyperuricemia by promoting uric acid excretion and inhibiting xanthine oxidase.
Chen Y; Zhao Z; Li Y; Yang Y; Li L; Jiang Y; Lin C; Cao Y; Zhou P; Tian Y; Wu T; Pang J
Phytomedicine; 2021 Jan; 80():153374. PubMed ID: 33075645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
